HCW Biologics Inc. (HCWB)
0.43
+0.01
(+2.63%)
USD |
NASDAQ |
Apr 17, 16:00
0.43
0.00 (0.00%)
After-Hours: 20:00
HCW Biologics EPS Diluted (Quarterly) : -1.024 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| AbbVie, Inc. | 1.018 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Longeveron, Inc. | -0.2374 |
| Q32 Bio, Inc. | 4.584 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.466M |
| Revenue (Quarterly) | 0.027M |
| Total Expenses (Quarterly) | 3.493M |
| Enterprise Value | 6.231M |
| Gross Profit Margin (Quarterly) | -561.1% |
| Profit Margin (Quarterly) | -12.84K% |
| Earnings Yield | -2.74K% |
| Normalized Earnings Yield | -3257.77 |